| Title |
Patenting of University and Non-University Public Research Organisations in Germany: Evidence from Patent Applications for Medical Research Results
|
|---|---|
| Published in |
PLOS ONE, November 2010
|
| DOI | 10.1371/journal.pone.0014059 |
| Pubmed ID | |
| Authors |
Peter Tinnemann, Jonas Özbay, Victoria A. Saint, Stefan N. Willich |
| Abstract |
Patents are one of the most important forms of intellectual property. They grant a time-limited exclusivity on the use of an invention allowing the recuperation of research costs. The use of patents is fiercely debated for medical innovation and especially controversial for publicly funded research, where the patent holder is an institution accountable to public interest. Despite this controversy, for the situation in Germany almost no empirical information exists. The purpose of this study is to examine the amount, types and trends of patent applications for health products submitted by German public research organisations. |
Mendeley readers
The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 3% |
| Unknown | 32 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 7 | 21% |
| Student > Ph. D. Student | 7 | 21% |
| Researcher | 5 | 15% |
| Student > Doctoral Student | 3 | 9% |
| Other | 1 | 3% |
| Other | 3 | 9% |
| Unknown | 7 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Business, Management and Accounting | 5 | 15% |
| Medicine and Dentistry | 4 | 12% |
| Social Sciences | 3 | 9% |
| Economics, Econometrics and Finance | 3 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 6% |
| Other | 8 | 24% |
| Unknown | 8 | 24% |